<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2454">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05129215</url>
  </required_header>
  <id_info>
    <org_study_id>E2020016</org_study_id>
    <nct_id>NCT05129215</nct_id>
  </id_info>
  <brief_title>Development and Validation of The Post-CRT LARS Prediction Model (PORTLARS)</brief_title>
  <acronym>PORTLARS</acronym>
  <official_title>Development and Validation of a Nomogram to Predict Severe Bowel Dysfunction After Rectal Cancer Resection and Neoadjuvant Chemoradiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sixth Affiliated Hospital, Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bowel dysfunction is common after a restorative rectal cancer resection. Neoadjuvant&#xD;
      chemoradiotherapy is an influential factor that impairs bowel function and quality of life.&#xD;
      However, almost half patients who have received primary surgery with preoperative&#xD;
      radiotherapy are able to restore a good or moderate bowel function in the long term. This&#xD;
      multicenter observational study aims to identify the risk factors of severe bowel dysfunction&#xD;
      after rectal cancer resection and neoadjuvant chemoradiotherapy, in accordance with the LARS&#xD;
      score, and to build a model that predicts long-term major LARS in the early stage of&#xD;
      follow-up. Development and validation cohorts are enrolled from tertiary hospitals in China.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 6, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with major low anterior resection syndrome (LARS score)</measure>
    <time_frame>Over one year after restorative rectal cancer resection</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Low Anterior Resection Syndrome</condition>
  <condition>Chemoradiotherapy</condition>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Development</arm_group_label>
    <description>A primary cohort of eligible patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for model derivation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Internal validation</arm_group_label>
    <description>An independent cohort of consecutive patients from the Sixth Affiliated Hospital of Sun Yat-sen University is used for internal validation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>External validation</arm_group_label>
    <description>An independent cohort of eligible patients from other hospitals is used for external validation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.</description>
    <arm_group_label>Development</arm_group_label>
    <arm_group_label>External validation</arm_group_label>
    <arm_group_label>Internal validation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent preoperative long-course radiotherapy, parallel chemotherapy, and&#xD;
        curative low anterior resection for nonmetastatic rectal cancer.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Curative low anterior resection for nonmetastatic rectal cancer&#xD;
&#xD;
          -  Preoperative long-course radiotherapy and parallel chemotherapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Death&#xD;
&#xD;
          -  Metastasis or recurrence&#xD;
&#xD;
          -  Postoperative radiotherapy&#xD;
&#xD;
          -  Cognitive disorder&#xD;
&#xD;
          -  Intestinal stoma&#xD;
&#xD;
          -  Rectal cancer resection for &lt;12 months&#xD;
&#xD;
          -  Stoma reversal for &lt;6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiyuan Qin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sixth Affiliated Hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sixth Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 15, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bowel Dysfunction</keyword>
  <keyword>Low Anterior Resection Syndrome</keyword>
  <keyword>Chemoradiotherapy</keyword>
  <keyword>Rectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

